FREE SHIPPING ON ORDERS OVER $150

glutathione cancer pathophysiology and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression: Cancer Cell Glutathione-mediated nanomedicines for cancer diagnosis

$21.57

Quantity
- +
Description

In addition, inhibition of GLS has been reported to increase the immunotherapy efficacy of CD8 + T cells (Johnson et al., 2018

glutathione cancer pathophysiology and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression: Cancer Cell Glutathione-mediated nanomedicines for cancer diagnosis

Wang Z, Weitzmann MN, Sangadala S, Hutton WC, Yoon ST

glutathione cancer pathophysiology and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression: Cancer Cell Glutathione-mediated nanomedicines for cancer diagnosis

* NRV is the Nutrient Reference Value

glutathione cancer pathophysiology and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression: Cancer Cell Glutathione-mediated nanomedicines for cancer diagnosis

Green CJ, Pedersen M, Pedersen BK, Scheele C

glutathione cancer pathophysiology and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression: Cancer Cell Glutathione-mediated nanomedicines for cancer diagnosis

14:e15343

glutathione cancer pathophysiology and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression: Cancer Cell Glutathione-mediated nanomedicines for cancer diagnosis

You may also like

FastandUp

US$ 29.08

4.2 (20 reviews)

recommand products